This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1990 Aug 15;143(4):265-7.

New drugs for hypertension: should data precede conclusions?

M G Myers¹

Affiliations

PMID: 2200600
PMCID: PMC1452182

Review

New drugs for hypertension: should data precede conclusions?

M G Myers. CMAJ. 1990.

. 1990 Aug 15;143(4):265-7.

Author

M G Myers¹

Affiliation

¹ Division of Cardiology, Sunnybrook Medical Centre, Toronto, Ont.

PMID: 2200600
PMCID: PMC1452182

No abstract available

PubMed Disclaimer

Similar articles

Should dihydropyridines be used as first-line drugs in the treatment of hypertension? The con side.
Furberg CD, Psaty BM. Furberg CD, et al. Arch Intern Med. 1995 Nov 13;155(20):2157-61. Arch Intern Med. 1995. PMID: 7487237 Review. No abstract available.
[The pharmacotherapy of arterial hypertension and the prevention of cardiovascular events. From evidence-based medicine to the new therapeutic opportunities].
Taddei S. Taddei S. Recenti Prog Med. 1999 Jan;90(1):4-8. Recenti Prog Med. 1999. PMID: 10193156 Review. Italian. No abstract available.
[Arterial essential hypertension and associated pathologies].
Jazra C. Jazra C. J Med Liban. 1999 Nov-Dec;47(6):343-8. J Med Liban. 1999. PMID: 10758708 Review. French. No abstract available.
Cardiometabolic risk-factor management.
Ker J. Ker J. Cardiovasc J Afr. 2008 Jul-Aug;19(4):222-4. Cardiovasc J Afr. 2008. PMID: 18776972 No abstract available.
[Antihypertensive treatment of the elderly. Does it help?].
Nielsen WB, Jensen GB. Nielsen WB, et al. Ugeskr Laeger. 1998 Oct 19;160(43):6195-7. Ugeskr Laeger. 1998. PMID: 9803866 Danish. No abstract available.

See all similar articles

Cited by

Report of the Canadian Hypertension Society Consensus Conference: 1. Introduction.
Carruthers SG, Larochelle P, Haynes RB, Petrasovits A, Schiffrin EL. Carruthers SG, et al. CMAJ. 1993 Aug 1;149(3):289-93. CMAJ. 1993. PMID: 8339174 Free PMC article. Review. No abstract available.
Fixed-dose combination therapy: panacea or poison?
Rao RB, Goldfrank LR. Rao RB, et al. Intensive Care Med. 1998 Apr;24(4):283-5. doi: 10.1007/s001340050569. Intensive Care Med. 1998. PMID: 9609404 Review. No abstract available.
"Drug may have caused huge number of deaths": lessons learned during an encounter with The Fifth Estate.
Myers MG. Myers MG. CMAJ. 1996 Sep 15;155(6):772-5. CMAJ. 1996. PMID: 8823222 Free PMC article.

References

1. Prog Cardiovasc Dis. 1985 Mar-Apr;27(5):335-71 - PubMed
1. Lancet. 1985 Jun 15;1(8442):1349-54 - PubMed
1. Clin Pharmacol Ther. 1986 Mar;39(3):239-44 - PubMed
1. CMAJ. 1989 May 15;140(10):1141-6 - PubMed
1. Can J Cardiol. 1989 Oct;5(7):335-6 - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Europe PubMed Central
- PubMed Central
Medical
- MedlinePlus Health Information